Inflammatory cytokine: IL-17A signaling pathway in patients present with COVID-19 and current treatment strategy

T Shibabaw - Journal of inflammation research, 2020 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is a globally communicable public health
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) …
被引用次数：102 相关文章

Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.

T Shibabaw - Journal of Inflammation Research, 2020 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is a globally communicable public health
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) …

[引用][C] Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy

T Shibabaw - Journal of Inflammation Research, 2020 - cir.nii.ac.jp
<p>Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and
Current Treatment Strategy</p> | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy

T Shibabaw - Journal of inflammation research, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is a globally communicable public health disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Eradication of …

Inflammatory Cytokine: IL-I7A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.

T Shibabaw - Journal of Inflammation Research, 2020 - go.gale.com
Coronavirus disease 2019 (COVID-19) is a globally communicable public health disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Eradication of …

Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy

T Shibabaw - Journal of Inflammation Research, 2020 - search.proquest.com
Abstract Coronavirus disease 2019 (COVID-19) is a globally communicable public health
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) …
[HTML] nih.gov

[HTML][HTML] Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy

T Shibabaw - Journal of Inflammation Research, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a globally communicable public health
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) …

Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy

T Shibabaw - Journal of Inflammation Research, 2020 - dovepress.com
Coronavirus disease 2019 (COVID-19) is a globally communicable public health disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2). Eradication of …